Newsmeme!
Discover News you didn't know existed
FAYETTEVILLE — Residents gathered recently to give a girl a new chance at winning her battle with cancer.
Sunday was a day to honor two beloved figures in Hawaiian culture: King Kalakaua and hula legend George Naope.
Researchers report promising results for the viability of a portable, handheld device using a specialized light technique that may enhance the differential diagnosis of non-melanoma skin cancers, inflamed scar tissue and normal skin in vivo.
Cardium Therapeutics (Amex: CXM) and its operating unit InnerCool Therapies, Inc., today announced that it has developed a pelvic cooling catheter system called UroCool(TM), which is designed to induce localized cooling during surgery for prostate cancer (radical prostatectomy). The new technology is being applied in collaboration with renowned prostate surgeon, Thomas E. Ahlering, M.D.
Researchers report promising results for the viability of a portable, handheld device using a specialized light technique that may enhance the differential diagnosis of non-melanoma skin cancers, inflamed scar tissue and normal skin in vivo. Recently published in "Lasers in Surgery and Medicine" (August 2008 issue), the peer-reviewed professional journal of the American Society for Laser ...
UroToday.com - One of the international leaders in laparoscopic radical prostatectomy, Jens-Uwe Stozenburg from Leipzig, Germany and associates has reported on the use of salvage laparoscopic extra-peritoneal radical prostatectomy (EERPE) following failed high intensity focused ultrasound therapy (HIFU), external beam radiotherapy (ERBT) or brachytherapy.
Technically, the Christmas Seals program is 101 years old because the first year of its use in America was 1907.
Researchers have found a tiny snippet of RNA that acts as a molecular “safety switch,” to prevent the spread of many cancers. Without the RNA switch keeping it in check, a cancer-promoting enzyme is freed to trigger the spread of prostate cancer.
Protox Therapeutics Inc. , a leader in the development of receptor targeted fusion proteins, today released third quarter 2008 financial results for the three months ended September 30, 2008 .
Breslow's 'First Pitch'
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |